NCT03523130View on ClinicalTrials.gov

Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific Inflammation

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

May 3, 2018

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
HIV
Interventions
DIAGNOSTIC_TEST

Imaging

Macrophage-specific inflammation

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03523130 - Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific Inflammation | Biotech Hunter | Biotech Hunter